"Psychiatrists should provide regular physical health monitoring because in most cases they are the only physicians visited by the psychotic patients. There is a clinical need to monitor antipsychotic-treated patients for metabolit, cardiovascular, neurological and andocrine disturbance and to develop collaborations with primary care physicians, diabetes specialists, and cardiologists to facilitate appropriate medical care for these patients. Antipsychotic-treated patients should also receive regular visual examinations. The monitoring of physical health of patients with schizophrenia increases safety and tolerability of antipsychotics treatment and decreases morbidity and mortality."@en . "Quo vadis, psychiatria?" . . "Z(MSM0021620816), Z(MZ0FNHK2005)" . . "Psychiat\u0159i by m\u011Bli zaji\u0161\u0165ovat pravideln\u00E9 sledov\u00E1n\u00ED somatick\u00E9ho zdrav\u00ED vzhledem k tomu, \u017Ee jsou v mnoha p\u0159\u00EDpadech jedin\u00FDmi l\u00E9ka\u0159i, kter\u00E9 nemocn\u00ED s psychotickou poruchou nav\u0161t\u011Bvuj\u00ED. Z klinick\u00E9ho hlediska je t\u0159eba u nemocn\u00FDch l\u00E9\u010Den\u00FDch antipsychotiky monitorovat metabolick\u00E9, kardiovaskul\u00E1rn\u00ED, neurologick\u00E9 a endokrinn\u00ED poruchy. Rozv\u00EDjen\u00ED spolupr\u00E1ce psychiatra s praktick\u00FDmi l\u00E9ka\u0159i, diabetology a kardiology podporuje pot\u0159ebnou medic\u00EDnskou p\u00E9\u010Di o nemocn\u00E9. U nemocn\u00FDch l\u00E9\u010Den\u00FDch antipsychotiky s vadou zraku by m\u011Bly b\u00FDt prov\u00E1d\u011Bny pravideln\u00E9 oftalmologick\u00E9 kontroly. Pravideln\u00E9 sledov\u00E1n\u00ED t\u011Blesn\u00E9ho zdrav\u00ED nemocn\u00FDch se schizofreni\u00ED zvy\u0161uje bezpe\u010Dnost a sn\u00E1\u0161enlivost antipsychotick\u00E9 medikace a sni\u017Euje morbiditu a mortalitu." . . . . "Praha" . "Mal\u00FD, Radovan" . . . . "Psychiat\u0159i by m\u011Bli zaji\u0161\u0165ovat pravideln\u00E9 sledov\u00E1n\u00ED somatick\u00E9ho zdrav\u00ED vzhledem k tomu, \u017Ee jsou v mnoha p\u0159\u00EDpadech jedin\u00FDmi l\u00E9ka\u0159i, kter\u00E9 nemocn\u00ED s psychotickou poruchou nav\u0161t\u011Bvuj\u00ED. Z klinick\u00E9ho hlediska je t\u0159eba u nemocn\u00FDch l\u00E9\u010Den\u00FDch antipsychotiky monitorovat metabolick\u00E9, kardiovaskul\u00E1rn\u00ED, neurologick\u00E9 a endokrinn\u00ED poruchy. Rozv\u00EDjen\u00ED spolupr\u00E1ce psychiatra s praktick\u00FDmi l\u00E9ka\u0159i, diabetology a kardiology podporuje pot\u0159ebnou medic\u00EDnskou p\u00E9\u010Di o nemocn\u00E9. U nemocn\u00FDch l\u00E9\u010Den\u00FDch antipsychotiky s vadou zraku by m\u011Bly b\u00FDt prov\u00E1d\u011Bny pravideln\u00E9 oftalmologick\u00E9 kontroly. Pravideln\u00E9 sledov\u00E1n\u00ED t\u011Blesn\u00E9ho zdrav\u00ED nemocn\u00FDch se schizofreni\u00ED zvy\u0161uje bezpe\u010Dnost a sn\u00E1\u0161enlivost antipsychotick\u00E9 medikace a sni\u017Euje morbiditu a mortalitu."@cs . "RIV/00216208:11150/08:00106640" . "Screening kardiometabolick\u00E9ho rizika u nemocn\u00FDch schizofreni\u00ED"@cs . "schizophrenia; antipsychotics; long-term therapy; side effects"@en . "Monitoring of cardiometabolic risk in patients with schizophrenia"@en . "978-80-7262-567-3" . "Kalnick\u00E1, Dita" . . . "[75F2D7FBEF5F]" . "4"^^ . "11150" . "3"^^ . "393911" . "Konup\u010D\u00EDkov\u00E1, Kate\u0159ina" . . . . . . "Masopust, Ji\u0159\u00ED" . "Gal\u00E9n" . . . "Screening kardiometabolick\u00E9ho rizika u nemocn\u00FDch schizofreni\u00ED"@cs . . "RIV/00216208:11150/08:00106640!RIV09-MZ0-11150___" . "Monitoring of cardiometabolic risk in patients with schizophrenia"@en . "4"^^ . "Screening kardiometabolick\u00E9ho rizika u nemocn\u00FDch schizofreni\u00ED" . . "Screening kardiometabolick\u00E9ho rizika u nemocn\u00FDch schizofreni\u00ED" .